FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes
Approval of Lantidra, a beta cell therapy derived from donor pancreatic islets, came despite transplant surgeons ' concerns about FDA regulating these cells as biologics rather than transplanted organs.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Diabetes & Endocrinology News Alert Source Type: news
More News: Diabetes | Diabetes Type 1 | Endocrinology | Intensive Care | Pancreas | Transplant Surgery | Transplants